tiprankstipranks
Japan Hospice Holdings Inc. (JP:7061)
:7061
Japanese Market
Want to see JP:7061 full AI Analyst Report?

Japan Hospice Holdings Inc. (7061) AI Stock Analysis

0 Followers

Top Page

JP:7061

Japan Hospice Holdings Inc.

(7061)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
¥572.00
▼(-48.93% Downside)
Action:Reiterated
Date:05/19/26
The score is primarily weighed down by weakening profitability, high leverage, and consistently negative free cash flow, which increases financing and execution risk. Technicals add further pressure due to a clear downtrend and weak momentum. Valuation is somewhat supportive with a moderate P/E and solid dividend yield, but not enough to offset the fundamental and technical headwinds.
Positive Factors
Consistent Revenue Growth
Sustained top-line growth across multiple years indicates durable demand for the company’s hospice and palliative services and demonstrates successful scaling of facilities and service delivery. This persistent revenue base supports longer-term planning and potential incremental margin recovery if cost pressures are addressed.
Negative Factors
High Leverage
Elevated leverage constrains strategic flexibility and raises refinancing and interest-cost risk over the medium term. Large debt relative to equity limits capacity to fund expansion organically, increases vulnerability to cash-flow shocks, and may force priority on debt servicing over reinvestment.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained top-line growth across multiple years indicates durable demand for the company’s hospice and palliative services and demonstrates successful scaling of facilities and service delivery. This persistent revenue base supports longer-term planning and potential incremental margin recovery if cost pressures are addressed.
Read all positive factors

Japan Hospice Holdings Inc. (7061) vs. iShares MSCI Japan ETF (EWJ)

Japan Hospice Holdings Inc. Business Overview & Revenue Model

Company Description
Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable di...
How the Company Makes Money
null...

Japan Hospice Holdings Inc. Financial Statement Overview

Summary
Revenue has grown steadily, but 2025 profitability weakened sharply (gross/net margin compression and lower net income despite higher sales). The balance sheet remains highly leveraged (debt-to-equity ~3.6x) and returns have deteriorated. Cash quality is a key concern: operating cash flow is positive, yet cash conversion is weak and free cash flow has been negative in most years, including deeply negative in 2024–2025.
Income Statement
58
Neutral
Balance Sheet
45
Neutral
Cash Flow
34
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.75B14.17B12.12B9.87B7.89B6.02B
Gross Profit2.10B1.84B2.11B1.92B1.58B1.12B
EBITDA1.64B1.43B1.82B1.79B1.40B852.01M
Net Income302.58M278.01M639.58M681.88M454.73M240.80M
Balance Sheet
Total Assets18.58B18.92B18.31B15.16B11.45B9.15B
Cash, Cash Equivalents and Short-Term Investments1.78B2.01B1.53B1.88B1.51B1.04B
Total Debt13.06B13.18B13.19B10.89B8.09B6.67B
Total Liabilities15.02B15.25B14.86B12.47B9.41B7.61B
Stockholders Equity3.56B3.68B3.45B2.69B2.01B1.54B
Cash Flow
Free Cash Flow0.00-1.32B-2.27B-865.26M340.76M-1.45B
Operating Cash Flow0.001.05B835.74M1.13B873.83M467.10M
Investing Cash Flow0.00-511.73M-2.79B-1.01B48.27M-1.98B
Financing Cash Flow0.00-47.03M1.60B256.45M-448.16M1.59B

Japan Hospice Holdings Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1120.00
Price Trends
50DMA
609.40
Negative
100DMA
703.69
Negative
200DMA
954.95
Negative
Market Momentum
MACD
-3.11
Negative
RSI
52.43
Neutral
STOCH
79.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7061, the sentiment is Negative. The current price of 1120 is above the 20-day moving average (MA) of 553.50, above the 50-day MA of 609.40, and above the 200-day MA of 954.95, indicating a neutral trend. The MACD of -3.11 indicates Negative momentum. The RSI at 52.43 is Neutral, neither overbought nor oversold. The STOCH value of 79.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7061.

Japan Hospice Holdings Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥44.22B12.042.63%3.49%-14.24%
58
Neutral
¥36.67B12.670.91%9.10%-54.63%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
51
Neutral
¥5.38B51.354.07%4.85%-85.27%
51
Neutral
¥2.47B21.922.56%-6.54%-69.23%
46
Neutral
¥4.95B16.281.41%16.83%-45.33%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7061
Japan Hospice Holdings Inc.
584.00
-401.88
-40.76%
JP:2373
Care Twentyone Corporation
400.00
-10.07
-2.46%
JP:2425
Care Service Co., Ltd.
665.00
-130.16
-16.37%
JP:6062
Charm Care Corporation
1,346.00
75.49
5.94%
JP:7071
Amvis Holdings.Inc.
372.00
-112.79
-23.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 19, 2026